ATENOLOL AND CHLORTHALIDONE
NDC 10135-733, atenolol and chlorthalidone tablet, tablet, from MARLEX PHARMACEUTICALS, INC.
- Product NDC
- 10135-733
- Status
- Listed
- Labeler
- MARLEX PHARMACEUTICALS, INC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215560
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORTHALIDONE25 mg/1
- ATENOLOL50 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; Increased Diuresis [PE]; Thiazide-like Diuretic [EPC]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-733-01 | 10135073301 | 100 TABLET in 1 BOTTLE (10135-733-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/db22ff31-52f6-9024-e053-2995a90af8b3
Use it
Look up 10135-733 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-733. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.